FINWIRES · TerminalLIVE
FINWIRES

最新情報:バジャーメーターの株価、第1四半期決算と売上高が市場予想を下回ったことを受け下落

-- (見出しと冒頭段落に最近の株価動向を追記しました。) バジャー・メーター(BMI)の株価は、同社の第1四半期決算と売上高がアナリスト予想を下回ったことを受け、金曜午後の取引で23%以上急落した。 同社は金曜、第1四半期の1株当たり利益が希薄化後0.93ドルとなり、前年同期の1.30ドルから減少したと発表した。 ファクトセットが調査したアナリストは1.22ドルを予想していた。 3月31日締めの第1四半期の売上高は2億230万ドルで、前年同期の2億2220万ドルから減少した。 ファクトセットが調査したアナリストは2億2960万ドルを予想していた。 同社は、英国のUDliveを1億ドル(条件付き支払いを含む)で買収することに合意したと発表した。これにより、下水監視事業が強化される。買収は2026年4月末までに完了する予定で、手元資金で賄われる。

Price: $116.69, Change: $-35.60, Percent Change: -23.38%

Related Articles

Asia

Update: Origin Energy Reports Lower March Quarter Production; Shares Fall 3%

(Updates to add stock movement in the headline and last paragraph)Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.The company reported commodity revenue of AU$1.86 billion for the quarter, down from AU$ 2.31 billion a year ago, per the filing.Origin Energy also said its electricity sales volume increased 4% from a year earlier amid "strong growth" in business volumes driven largely by the data-center sector.The company's shares fell 3% in recent Monday trade.

$ASX:ORG
Asia

Alterity Therapeutics Secures US FDA Support for ATH434 Phase Three Program

Alterity Therapeutics (ASX:ATH) said it received positive feedback from a second type C meeting with the US Food and Drug Administration (FDA) on its planned phase three program for drug candidate ATH434, aimed at treating multiple system atrophy (MSA), according to a Monday filing with the Australian bourse.MSA is a progressive neurodegenerative disorder affecting autonomic and motor function with no approved disease-modifying therapies.The US FDA provided supportive written feedback on the program's chemistry, manufacturing, and controls, complementing earlier guidance from a separate type C meeting on clinical pharmacology and non-clinical development, the filing added.

$ASX:ATH
Asia

Xinyuan Property Management's CFO Resigns

Xinyuan Property Management Service's (HKG:1895) chief financial officer, Wang Yong, has resigned, effective April 26, according to a Monday Hong Kong bourse filing.Wang stepped down to devote more time to personal commitments, the company said.The company said the resignation will not affect its normal operations, with Wang's duties to be reallocated internally on an interim basis.Xinyuan Property Management added that it is seeking a suitable replacement for the chief financial officer role.

$HKG:1895